Esperion Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $103k | 39k | 2.64 |
| 2024-12-31 | $209k | 95k | 2.20 |
| 2024-06-30 | $1.8M | 813k | 2.22 |
| 2024-03-31 | $1.2M | 449k | 2.68 |
| 2023-12-31 | $3.4M | 1.1M | 2.99 |
| 2023-09-30 | $1.1M | 1.1M | 0.98 |
| 2023-06-30 | $599k | 431k | 1.39 |
| 2023-03-31 | $179k | 113k | 1.59 |
| 2022-12-31 | $113k | 18k | 6.20 |
| 2021-09-30 | $285k | 24k | 12.06 |
| 2020-12-31 | $522k | 20k | 25.98 |
| 2020-09-30 | $485k | 13k | 37.16 |
| 2019-06-30 | $707k | 15k | 46.52 |
| 2017-09-30 | $454k | 9.1k | 50.17 |
| 2017-06-30 | $449k | 9.7k | 46.26 |
| 2017-03-31 | $1.3M | 36k | 35.32 |
| 2015-09-30 | $752k | 32k | 23.58 |
| 2015-06-30 | $711k | 8.7k | 81.72 |